Alder Biopharmaceuticals

ALDR

8.80

-0.15

-1.7%

After Hours:

8.80

0.00

0.0%

Please Subscribe or Register

Login|Subscribe|Register

Stock Price
Open: 8.90
Prev. Close: 8.95
Low/Hi: 8.75 - 9.00
52-Week: 8.80 - 36.48
Volumes
Equity: 919,092
90-Day Avg: 1,478,206
Option: 688
90-Day Avg: 678
Volatility
Todays Stock Vol: 23.2
20-Day (HV): 68.4
52-Week (HV): 69.6
30-Day IV: 67.2 +5.7
IV Pct Rank: 71% Moderate
Fundamental
Div. Yield: 0.0%
Earnings: 3-Nov (Est.)
P/E Ratio:
Market Cap: 606.0 M
Stock Type: Common
Sector: Healthcare
Industry: Biotechnology
Stock Type: Common | Sector: Healthcare | Industry: Biotechnology

ALDR Balance Sheet

Numbers are in thousands. Data provided by Sage Data Service.
Period Ending 30-Jun-2017 31-Mar-2017 31-Dec-2016 30-Sep-2016
Cash and Cash Equivalents 127,789 79,713 116,216 170,632
Short Term Investments 96,692 209,851 235,651 232,757
Investments - - - -
Accounts Receivable 0 0 0 0
Inventory 936 936 936 936
Loans - - - -
Prepaid Expenses 21,221 19,827 40,380 23,682
Net Property Plant and Equipment 6,714 6,776 7,076 6,610
Other Current Assets 0 0 0 0
Current Assets 246,638 310,327 393,183 428,007
Goodwill and Intangibles 0 0 0 0
Long Term Investments 586 716 865 956
Other Assets - - - -
Long Term Receivables 0 0 0 0
Total Assets 253,968 317,849 409,154 443,603
Short Term Debt 0 0 0 0
Other Non-Current Assets 30 30 8,030 8,030
Accounts Payable 19,796 20,300 10,361 5,703
Accrued Liabilities and Other Payables 14,236 9,243 15,437 10,952
Long Term Debt 0 0 0 0
Other Liabilities - - - -
Current Portion of Long Term Debt 0 0 0 0
Total Liabilities 34,547 30,090 26,371 16,867
Other Current Liabilities 92 92 92 96
Accumulated Other Comprehensive Income -68 5 -48 60
Preferred Stock 0 0 0 0
Current Liabilities 34,124 29,635 25,890 16,751
Common Stock 5 5 5 5
Other Non-Current Liabilities 423 455 481 116
Additional Paid-In Capital 773,071 766,707 761,456 756,410
Treasury Stock 0 0 0 0
Other Equity 0 0 0 0
Retained Earnings -553,587 -478,958 -378,630 -329,739
Total Equity 219,421 287,759 382,783 426,736
Period Ending 31-Dec-2016 31-Dec-2015 31-Dec-2014
Cash and Cash Equivalents 116,216 206,492 46,795
Short Term Investments 235,651 98,680 9,077
Investments - - -
Accounts Receivable 0 0 113
Inventory 936 0 0
Loans - - -
Prepaid Expenses 40,380 17,029 4,758
Net Property Plant and Equipment 7,076 1,974 1,160
Other Current Assets 0 0 0
Current Assets 393,183 322,201 60,743
Goodwill and Intangibles 0 0 0
Long Term Investments 865 75,840 0
Other Assets - - -
Long Term Receivables 0 0 0
Total Assets 409,154 400,027 64,359
Short Term Debt 0 0 0
Other Non-Current Assets 8,030 12 2,456
Accounts Payable 10,361 4,727 1,911
Accrued Liabilities and Other Payables 15,437 7,583 2,963
Long Term Debt 0 0 0
Other Liabilities - - -
Current Portion of Long Term Debt 0 0 0
Total Liabilities 26,371 12,510 5,202
Other Current Liabilities 92 62 135
Accumulated Other Comprehensive Income -48 -501 -22
Preferred Stock 0 0 0
Current Liabilities 25,890 12,372 5,009
Common Stock 5 4 3
Other Non-Current Liabilities 481 138 193
Additional Paid-In Capital 761,456 610,390 196,082
Treasury Stock 0 0 0
Other Equity 0 0 0
Retained Earnings -378,630 -222,376 -136,906
Total Equity 382,783 387,517 59,157